Preparation of multiparticulate systems for oral delivery of a micronized or nanosized poorly soluble drug

References

• Ghebre-Sellassie I. Pharmaceutical pelletization technology. New York: Marcel Dekker Inc.; 1989.
   Google Scholar
• Hoang Thi TH, Lhafidi S, Carneiro SP, Flament MP. Feasability of a new process to produce fast disintegrating pellets as novel multiparticulate dosage form for pediatric use. Int J Pharm 2015;496:842–9.
   PubMed Web of Science ®Google Scholar
• Follonier N, Doelker E. Biopharmaceutical comparison of oral multiple-unit and single-unit sustained-release dosage forms. STP Pharma Sci 1992;2:141--55.
   Google Scholar
• Namburi RR, Kerr JE. Oral itraconazole formulations and methods of making the same [Internet]. US 6663897 B2, 2002 [cited 2015 Oct 7]. Available from: http://www.google.com/patents/WO2002062318A3?cl=en
   Google Scholar
• Gilis P, De Conde V, Vandecruys R, Pellets having a core coated with an antifungal and a polymer [Internet]. United States; 20050142188 A1, 2005 [cited 2015 Oct 7]. Available from: https://www.google.com/patents/US20050142188?dq=pellets+having+a+core+coated+with+antifungal+and+polymer&hl=it&sa=X&ved=0CDgQ6AEwA2oVChMIisiHw76wyAIVAckUCh11NgkL
   Google Scholar
• Dukić-Ott A, Thommes M, Remon JP, et al. Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review. Eur J Pharm Biopharm 2009;71:38–46.
   PubMed Web of Science ®Google Scholar
• Tatavarti A, Kesisoglou F. An extrusion spheronization approach to enable a high drug load formulation of a poorly soluble drug with a low melting surfactant. J Pharm Sci 2015;104:3752–9.
   PubMed Web of Science ®Google Scholar
• Pinto J, Müller RH. Pellets as carriers of solid lipid nanoparticles (SLN) for oral administration of drugs. Pharmazie 1999;54:506–9.
   Web of Science ®Google Scholar
• Liew CV, Gu L, Soh JL, Heng PW. Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose. Pharm Res 2005;22:1387–98.
   PubMed Web of Science ®Google Scholar
• Zema L, Palugan L, Maroni A, et al. The use of ß-cyclodextrin in the manufacturing of disintegrating pellets with improved dissolution performances. AAPS PharmSciTech 2008;9:708–17.
   PubMed Web of Science ®Google Scholar
• Verheyen P, Steffens KJ, Kleinebudde P. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties. Drug Dev Ind Pharm 2009;35:1325–32.
   PubMed Web of Science ®Google Scholar
• Goyanes A, Souto C, Martínez-Pacheco R. A comparison of chitosan-silica and sodium starch glycolate as disintegrants for spheronized extruded microcrystalline cellulose pellets. Drug Dev Ind Pharm 2011;37:825–31.
   PubMed Web of Science ®Google Scholar
• Merisko-Liversidge E, Liversidge GG, Cooper ER. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci 2003;18:113–20.
   PubMed Web of Science ®Google Scholar
• Mou D, Chen H, Wan J, et al. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility. Int J Pharm 2011;413:237–44.
   PubMed Web of Science ®Google Scholar
• Plakkot S, de Matas M, York P, et al. Comminution of ibuprofen to produce nano-particles for rapid dissolution. Int J Pharm 2011;415:307–14.
   PubMed Web of Science ®Google Scholar
• Gao L, Liu G, Ma J, et al. Drug nanocrystals: in vivo performances. J Control Release 2012;160:418–30.
   PubMed Web of Science ®Google Scholar
• Möschwitzer JP. Drug nanocrystals in the commercial pharmaceutical development process. Int J Pharm 2013;453:142–56.
   PubMed Web of Science ®Google Scholar
• Deol PK, Kaur IP. Improving the therapeutic efficiency of ginger extract for treatment of colon cancer using a suitably designed multiparticulate system. J Drug Target 2013;21:855–65.
   PubMed Web of Science ®Google Scholar
• Mimi N, Belkacemi H, Sadoun T, et al. How the composition and manufacturing parameters affect insulin release from polymeric nanoparticles. J Drug Deliv Sci Technol 2015;30:458–66.
   Web of Science ®Google Scholar
• McDonald BF, Coulter IS, Marison IW. Microbeads: a novel multiparticulate drug delivery technology for increasing the solubility and dissolution of celecoxib. Pharm Dev Technol 2015;20:211–18.
   PubMed Web of Science ®Google Scholar
• Leleux J, Williams RO. Recent advancements in mechanical reduction methods: particulate systems. Drug Dev Ind Pharm 2014;40:289–300.
   PubMed Web of Science ®Google Scholar
• Dong Y, Feng S-S. Poly(d, l-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy. Int J Pharm 2007;342:208–14.
   PubMed Web of Science ®Google Scholar
• Sun W, Mao S, Shi Y, et al. Nanonization of itraconazole by high pressure homogenization: stabilizer optimization and effect of particle size on oral absorption. J Pharm Sci 2011;100:3365–73.
   PubMed Web of Science ®Google Scholar
• Salazar J, Heinzerling O, Müller RH, Möschwitzer JP. Process optimization of a novel production method for nanosuspensions using design of experiments (DoE). Int J Pharm 2011;420:395–403.
   PubMed Web of Science ®Google Scholar
• Junghanns JU, Müller RH. Nanocrystal technology, drug delivery and clinical applications. Int J Nanomedicine 2008;3:295–309.
   PubMed Web of Science ®Google Scholar
• Baert L, van’t Klooster G, Dries W, et al. Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment. Eur J Pharm Biopharm 2009;72:502–8.
   PubMed Web of Science ®Google Scholar
• Hanafy A, Spahn-Langguth H, Vergnault G, et al. Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug. Adv Drug Deliv Rev 2007;59:419–26.
   PubMed Web of Science ®Google Scholar
• Tuomela A, Liu P, Puranen J, et al. Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo. Int J Pharm 2014;467:34–41.
   PubMed Web of Science ®Google Scholar
• Shrewsbury SB, Bosco AP, Uster P. Pharmacokinetics of a novel submicron budesonide dispersion for nebulized delivery in asthma. Int J Pharm 2009;365:12–17.
   PubMed Web of Science ®Google Scholar
• Wu L, Zhang J, Watanabe W. Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev 2011;63:456–69.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zheng Y, Zhang L, et al. Stability of nanosuspensions in drug delivery. J Control Release 2013;172:1126–41.
   PubMed Web of Science ®Google Scholar
• Cerdeira AM, Mazzotti M, Gander B. Formulation and drying of miconazole and itraconazole nanosuspensions. Int J Pharm 2013;443:209–20.
   PubMed Web of Science ®Google Scholar
• Kumar S, Jog R, Shen J, et al. In vitro and in vivo performance of different sized spray-dried crystalline itraconazole. J Pharm Sci 2015;104:3018–28.
   PubMed Web of Science ®Google Scholar
• Niwa T, Miura S, Danjo K. Design of dry nanosuspension with highly spontaneous dispersible characteristics to develop solubilized formulation for poorly water-soluble drugs. Pharm Res 2011;28:2339–49.
   PubMed Web of Science ®Google Scholar
• Chaubal MV, Popescu C. Conversion of nanosuspensions into dry powders by spray drying: a case study. Pharm Res 2008;25:2302–8.
   PubMed Web of Science ®Google Scholar
• Dolenc A, Kristl J, Baumgartner S, Planinsek O. Advantages of celecoxib nanosuspension formulation and transformation into tablets. Int J Pharm 2009;376:204–12.
   PubMed Web of Science ®Google Scholar
• Badawi AA, El-Nabarawi MA, El-Setouhy DA, Alsammit SA. Formulation and stability testing of itraconazole crystalline nanoparticles. AAPS PharmSciTech 2011;12:811–20.
   PubMed Web of Science ®Google Scholar
• Peeters J, Neeskens P, Tollenaere JP, et al. Characterization of the interaction of 2-hydroxypropyl-beta-cyclodextrin with itraconazole at pH 2, 4, and 7. J Pharm Sci 2002;91:1414–22.
   PubMed Web of Science ®Google Scholar
• Reagents. Test solution. In: US Pharmacopeia 38 National Formulary 33:2015;1889.
   Google Scholar
• Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System Guidance for Industry, U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), Silver Spring, MD. Available from: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm.
   Google Scholar
• Cerea M, Pattarino F, Ochoa Maciste E, et al. Formulation of pellets containing nanosuspensions of a poorly soluble drug. AAPS Annual Meeting and Exposition; 2013. San Antonio, TX. p. M1175.
   Google Scholar
• Newton JM. Extrusion and extruders. In: Swarbrick J, Boylan JC, eds. Encyclopedia of pharmaceutical technology. New York: Marcel Dekker Inc.; 2002:1220–36.
   Google Scholar
• Shah RD, Kabadi M, Pope DG, Augsburger LL. Physicomechanical characterization of the extrusion-spheronization process. I. Instrumentation of the extruder. Pharm Res 1994;11:355–60.
   PubMed Web of Science ®Google Scholar
• Sonaglio D, Bataille B, Ortigosa C, Jacob M. Factorial design in the feasibility of producing Microcel MC 101 pellets by extrusion/spheronization. Int J Pharm 1995; 115:53–60.
   Web of Science ®Google Scholar
• Fielden KE, Newton JM, Rowe RC. The influence of lactose particle size on spheronization of extrudate processed by a ram extruder. Int J Pharm 1992;81:205–24.
   Web of Science ®Google Scholar
• Fielden KE, Newton JM, O’Brien P, Rowe RC. Thermal studies on the interaction of water and microcrystalline cellulose. J Pharm Pharmacol 1988;40:674–8.
   PubMed Web of Science ®Google Scholar
• Okada S, Nakahara H, Isaka H. Adsorption of drugs on microcrystalline cellulose suspended in aqueous solutions. Chem Pharm Bull (Tokyo) 1987;35:761–8.
   Web of Science ®Google Scholar
• Basit AW, Newton JM, Lacey LF. Formulation of ranitidine pellets by extrusion-spheronization with little or no microcrystalline cellulose. Pharm Dev Technol 1999;4:499–505.
   PubMed Web of Science ®Google Scholar
• Newton J, Chow A, Jeewa K. The effect of excipient source on spherical granules made by extrusion/spheronization. Pharm Tech Int 1992;4:52--8.
   Google Scholar
• O’Connor RE, Schwartz JB. Spheronization II: drug release from drug-diluent mixtures. Drug Dev Ind Pharm 1985;11:1837--57.
   Web of Science ®Google Scholar
• Ekiert RJ, Krzek J. Determination of azole antifungal medicines using zero-order and derivative UV spectrophotometry. Acta Pol Pharm 2009;66:19–24.
   PubMed Web of Science ®Google Scholar